SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

IOL Chemicals shines on successfully completing USFDA inspection

29 Oct 2019 Evaluate

IOL Chemicals & Pharmaceuticals is currently trading at Rs. 192.25, up by 7.55 points or 4.09% from its previous closing of Rs. 184.70 on the BSE.

The scrip opened at Rs. 190.00 and has touched a high and low of Rs. 194.00 and Rs. 187.40 respectively. So far 5507 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 234.90 on 30-May-2019 and a 52 week low of Rs. 123.10 on 29-Oct-2018.

Last one week high and low of the scrip stood at Rs. 194.00 and Rs. 171.30 respectively. The current market cap of the company is Rs. 1050.71 crore.

The promoters holding in the company stood at 41.89%, while Institutions and Non-Institutions held 2.13% and 55.98% respectively.

IOL Chemicals & Pharmaceuticals has received a communication from US Food & Drug Administration (USFDA) with respect to an inspection conducted by USFDA of Ibuprofen manufacturing facilities located at Trident Complex, Barnala in the state of Punjab from August 05, 2019 to August 09, 2019. USFDA has concluded that inspection is ‘closed’ under 21 CFR part 20.64(d)(3).

IOL Chemicals & Pharmaceuticals is a leading organic chemicals manufacturer and supplier in India.

IOL Chem & Pharma Share Price

96.98 -0.90 (-0.92%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×